Independent Franchise Partners’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03B Buy
15,733,495
+377,804
+2% +$28.1M 7.19% 2
2025
Q4
$1.22B Buy
15,355,691
+2,456,451
+19% +$188M 7.74% 1
2025
Q3
$942M Buy
12,899,240
+2,758,174
+27% +$202M 6.21% 1
2025
Q2
$769M Buy
10,141,066
+4,320,342
+74% +$306M 5.12% 9
2025
Q1
$443M Buy
5,820,724
+4,217,570
+263% +$314M 3.16% 17
2024
Q4
$106M Buy
1,603,154
+821,272
+105% +$57.5M 0.8% 23
2024
Q3
$54.5M Buy
+781,882
New +$47M 0.48% 24

Other funds holding SOLV

Independent Franchise Partners's SOLV Position: Q1 2026 in Review

Independent Franchise Partners increased its Solventum (SOLV) stake by 2.5% in Q1 2026, buying an estimated $28.1M and bringing the position to 15,733,495 shares worth $1.03B. The position accounts for 7.19% of the portfolio, ranked #2.

Independent Franchise Partners first reported a position in SOLV in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.22B in Q4 2025. 879 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Independent Franchise Partners held 15,733,495 shares of Solventum worth $1.03B as of Q1 2026.
  • Independent Franchise Partners bought 377,804 Solventum shares in Q1 2026, an estimated $28.1M.
  • Solventum made up 7.19% of Independent Franchise Partners's portfolio in Q1 2026, its #2 holding.
  • Independent Franchise Partners first reported a position in Solventum in Q3 2024 and has held it in 7 quarters since.
  • Independent Franchise Partners's Solventum position peaked at $1.22B in Q4 2025.
  • 879 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Independent Franchise Partners's 13F filing for Q1 2026, filed 14 May 2026.